Stay updated on Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Sign up to get notified when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.

Latest updates to the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe webpage has undergone significant changes in its content regarding the clinical trial for advanced solid tumors, specifically detailing the study's phases and treatment protocols. Notably, the trial's name and the version number have been updated.SummaryDifference50%
- Check28 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check36 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check72 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check86 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral Cavrotolimod With PD-1 Blockade Clinical Trial page.